All In Biotech

Drug Trial Radar · NCT07104032

IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

A Phase 3, Multiregional, Open-label, Randomized Study of Tirabrutinib vs Rituximab and Temozolomide in Participants With Relapsed/Refractory Primary Central Nervous System Lymphoma (IGNITE)

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 132 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

132

Planned (sponsor's estimate)

Start

Jun 12, 2026

Primary completion

Dec 2027

Study completion Dec 2029

Sponsor

Lead sponsor
Ono Pharmaceutical Co., Ltd.Industry
Sponsor type
Industry
Collaborators
Deciphera Pharmaceuticals, LLC
First posted
Aug 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical trial is to evaluate efficacy and safety of tirabrutinib alone compared with rituximab and temozolomide (R-TMZ) combination therapy in participants with Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL).

Conditions

  • Relapsed/Refractory Primary Central Nervous System Lymphoma

Interventions

  • TirabrutinibDrug

    Administered orally.

  • RituximabDrug

    Administered intravenously (IV).

  • TemozolomideDrug

    Administered orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression Free Survival (PFS)Time frame: Estimated up to 24 months

Locations

50 sites in 8 countries. Site status is shown where the registry gives one.

  • Mayo Clinic Cancer Center

    Phoenix, Arizona · Recruiting

  • HonorHealth Cancer Center

    Scottsdale, Arizona · Recruiting

  • Providence Medical Foundation

    Fullerton, California · Recruiting

  • UC Irvine Health

    Orange, California · Recruiting

  • Yale Cancer Center

    New Haven, Connecticut · Recruiting

  • John Hopkins University

    Washington D.C., District of Columbia · Recruiting

  • University of Florida Gainesville

    Gainesville, Florida · Recruiting

  • Mayo Clinic Cancer Center

    Jacksonville, Florida · Recruiting

  • University of Maryland

    Baltimore, Maryland · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Recruiting

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts · Recruiting

  • Dana-Farber Cancer Institute

    Boston, Massachusetts · Recruiting

  • Mayo Clinic Cancer Center

    Rochester, Minnesota · Recruiting

  • Hackensack University Medical Center

    Hackensack, New Jersey · Recruiting

  • Atlantic Health Overlook Medical Center

    Summit, New Jersey · Recruiting

  • NYU Langone Health

    New York, New York · Recruiting

  • Columbia University Irving Medical Center

    New York, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center

    New York, New York · Recruiting

  • University of Rochester Medicine Wilmot Cancer Institute - Webster

    Rochester, New York · Recruiting

  • Atrium Health Levine Cancer Institute

    Charlotte, North Carolina · Recruiting

  • Duke University Medical Center

    Durham, North Carolina · Recruiting

  • Providence Neurological Specialties West

    Portland, Oregon · Recruiting

  • Penn State Health Milton S Hershey Medical Center

    Hershey, Pennsylvania · Recruiting

  • University of Pennsylvania

    Philadelphia, Pennsylvania · Recruiting

  • UPMC Hillman Cancer Center

    Pittsburgh, Pennsylvania · Recruiting

  • Rhode Island Hospital

    Providence, Rhode Island · Recruiting

  • University of Washington

    Seattle, Washington · Recruiting

  • St Vincent's Hospital Sydney

    Darlinghurst, Australia, Australia · Recruiting

  • Epworth Healthcare

    Melbourne, Victoria, Australia · Recruiting

  • Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein

    São Paulo, Brazil · Recruiting

  • Hospital de Clínicas de Porto Alegre, Centro de Pesquisa Clinica

    Porto Alegre, Brazil, Brazil · Recruiting

  • University Hospital Ostrava

    Ostrava, Czechia, Czechia · Recruiting

  • University Hospital Královské Vinohrady

    Prague, Czechia, Czechia · Recruiting

  • Hôpitaux Civils de Colmar (HCC) Louis Pasteur

    Colmar, France, France · Recruiting

  • Hôpitaux de Marseille

    Marseille, France, France · Recruiting

  • Hospital Center University De Montpellier

    Montpellier, France, France · Recruiting

  • Centre Hospitalier Régional Universitaire (CHRU) de Tours - Hôpital Bretonneau

    Tours, France, France · Recruiting

  • Universitätsklinikum Würzburg

    Würzburg, Germany, Germany · Recruiting

  • Arcispedale S. Maria Nuova

    Reggio Emilia, Italy · Recruiting

  • ASST Papa Giovanni XXII

    Bergamo, Italy, Italy · Recruiting

Showing 40 of 50 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.